• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡萄球菌激酶激活纤溶酶原需要氨基末端蛋白水解。

Staphylokinase requires NH2-terminal proteolysis for plasminogen activation.

作者信息

Schlott B, Gührs K H, Hartmann M, Röcker A, Collen D

机构信息

Institute for Molecular Biotechnology, 07745 Jena, Germany.

出版信息

J Biol Chem. 1997 Feb 28;272(9):6067-72. doi: 10.1074/jbc.272.9.6067.

DOI:10.1074/jbc.272.9.6067
PMID:9038231
Abstract

Staphylokinase (Sak), a single-chain protein comprising 136 amino acids with NH2-terminal sequence,SSSFDKGKYKKGDDA forms a complex with plasmin, that is endowed with plasminogen activating properties. Plasmin is presumed to process mature (high molecular weight, HMW) Sak to low molecular weight derivatives (LMW-Sak), primarily by hydrolyzing the Lys10-Lys11 peptide bond, but the kinetics of plasminogen activation by HMW-Sak and LMW-Sak are very similar. Here, the requirement of NH2-terminal proteolysis of Sak for the induction of plasminogen activating potential was studied by mutagenesis of Lys10 and Lys11 in combination with NH2-terminal microsequence analysis of equimolar mixtures of Sak and plasminogen and determination of kinetic parameters of plasminogen activation by catalytic amounts of Sak. Substitution of Lys10 with Arg did not affect processing of the Arg10-Lys11 site nor plasminogen activation, whereas substitution with His resulted in cleavage of the Lys11-Gly12 peptide bond and abolished plasminogen activation. Substitution of Lys11 with Arg did not affect Lys10-Arg11 processing or plasminogen activation, whereas replacement with His did not prevent Lys10-His11 hydrolysis but abolished plasminogen activation. Substitution of Lys11 with Cys yielded an inactive processed derivative which was fully activated by aminoethylation. Deletion of the 10 NH2-terminal amino acids did not affect plasminogen activation, but additional deletion of Lys11 eliminated plasminogen activation. Thus generation of plasminogen activator potential in Sak proceeds via plasmin-mediated removal of the 10 NH2-terminal amino acids with exposure of Lys11 as the new NH2 terminus. This provides a structural basis for the hypothesis, derived from kinetic measurements, that plasminogen activation by Sak needs to be primed by plasmin and a mechanism for the high fibrin selectivity of Sak in a plasma milieu.

摘要

葡萄球菌激酶(Sak)是一种由136个氨基酸组成的单链蛋白,其氨基末端序列为SSSFDKGKYKKGDDA,它与纤溶酶形成复合物,具有纤溶酶原激活特性。据推测,纤溶酶主要通过水解Lys10-Lys11肽键将成熟的(高分子量,HMW)Sak加工成低分子量衍生物(LMW-Sak),但HMW-Sak和LMW-Sak激活纤溶酶原的动力学非常相似。在此,通过对Lys10和Lys11进行诱变,结合对Sak和纤溶酶原等摩尔混合物的氨基末端微序列分析以及测定催化量的Sak激活纤溶酶原的动力学参数,研究了Sak氨基末端蛋白水解对纤溶酶原激活潜能诱导的需求。用Arg取代Lys10既不影响Arg10-Lys11位点的加工,也不影响纤溶酶原激活,而用His取代则导致Lys11-Gly12肽键的裂解并消除了纤溶酶原激活。用Arg取代Lys11不影响Lys10-Arg11的加工或纤溶酶原激活,而用His取代虽不阻止Lys10-His11的水解,但消除了纤溶酶原激活。用Cys取代Lys11产生了一种无活性的加工衍生物,通过氨乙基化可使其完全激活。删除10个氨基末端氨基酸不影响纤溶酶原激活,但额外删除Lys11则消除了纤溶酶原激活。因此,Sak中纤溶酶原激活潜能的产生是通过纤溶酶介导去除10个氨基末端氨基酸,使Lys11暴露为新的氨基末端。这为基于动力学测量得出的假说提供了结构基础,即Sak激活纤溶酶原需要纤溶酶引发,也为Sak在血浆环境中对纤维蛋白具有高选择性的机制提供了依据。

相似文献

1
Staphylokinase requires NH2-terminal proteolysis for plasminogen activation.葡萄球菌激酶激活纤溶酶原需要氨基末端蛋白水解。
J Biol Chem. 1997 Feb 28;272(9):6067-72. doi: 10.1074/jbc.272.9.6067.
2
NH2-terminal structural motifs in staphylokinase required for plasminogen activation.葡萄球菌激酶中纤溶酶原激活所需的氨基末端结构基序。
J Biol Chem. 1998 Aug 28;273(35):22346-50. doi: 10.1074/jbc.273.35.22346.
3
Functional properties of recombinant staphylokinase variants obtained by site-specific mutagenesis of methionine-26.通过甲硫氨酸-26位点特异性诱变获得的重组葡萄球菌激酶变体的功能特性。
Biochim Biophys Acta. 1994 Feb 16;1204(2):235-42. doi: 10.1016/0167-4838(94)90013-2.
4
Analysis of plasminogen activation by the plasmin-staphylokinase complex in plasma of alpha2-antiplasmin-deficient mice.α2-抗纤溶酶缺陷小鼠血浆中纤溶酶-葡萄球菌激酶复合物对纤溶酶原激活作用的分析。
Blood Coagul Fibrinolysis. 2000 Oct;11(7):645-55. doi: 10.1097/00001721-200010000-00009.
5
Role of the N-terminal region of staphylokinase (SAK): evidence for the participation of the N-terminal region of SAK in the enzyme-substrate complex formation.葡萄球菌激酶(SAK)N 端区域的作用:SAK 的 N 端区域参与酶-底物复合物形成的证据
FEBS Lett. 2000 Jun 2;474(2-3):151-8. doi: 10.1016/s0014-5793(00)01578-7.
6
Staphylokinase as a plasminogen activator component in recombinant fusion proteins.葡萄球菌激酶作为重组融合蛋白中的纤溶酶原激活剂成分。
Appl Environ Microbiol. 1999 Feb;65(2):506-13. doi: 10.1128/AEM.65.2.506-513.1999.
7
Kinetic studies on the plasminogen activation by the staphylokinase-plasmin complex.葡萄球菌激酶 - 纤溶酶复合物激活纤溶酶原的动力学研究。
J Biochem. 1994 Apr;115(4):738-42. doi: 10.1093/oxfordjournals.jbchem.a124404.
8
Activation of human plasminogen by staphylokinase. Direct evidence that preformed plasmin is necessary for activation to occur.葡萄球菌激酶对人纤溶酶原的激活作用。激活过程中预先形成的纤溶酶必不可少的直接证据。
Blood. 1997 Mar 1;89(5):1585-9.
9
Purification and characterization of the bacterial plasminogen activator staphylokinase secreted by a recombinant Bacillus subtilis.重组枯草芽孢杆菌分泌的细菌纤溶酶原激活剂葡萄球菌激酶的纯化与特性分析
Zentralbl Bakteriol Mikrobiol Hyg A. 1988 Nov;269(3):314-22. doi: 10.1016/s0176-6724(88)80174-3.
10
Staphylokinase reduces plasmin formation by endogenous plasminogen activators.葡萄球菌激酶可减少内源性纤溶酶原激活剂形成纤溶酶。
Eur J Haematol. 2008 Jul;81(1):8-17. doi: 10.1111/j.1600-0609.2008.01066.x. Epub 2008 Mar 10.

引用本文的文献

1
Adhesive Virulence Factors of Resist Digestion by Coagulation Proteases Thrombin and Plasmin.抗凝血蛋白酶凝血酶和纤溶酶消化的黏附毒力因子。
ACS Bio Med Chem Au. 2022 Dec 21;2(6):586-599. doi: 10.1021/acsbiomedchemau.2c00042. Epub 2022 Sep 2.
2
Bacterial staphylokinase as a promising third-generation drug in the treatment for vascular occlusion.细菌葡激酶作为第三代治疗血管闭塞药物的研究进展。
Mol Biol Rep. 2020 Jan;47(1):819-841. doi: 10.1007/s11033-019-05167-x. Epub 2019 Nov 1.
3
Structural Biology and Protein Engineering of Thrombolytics.
溶栓剂的结构生物学与蛋白质工程
Comput Struct Biotechnol J. 2019 Jul 2;17:917-938. doi: 10.1016/j.csbj.2019.06.023. eCollection 2019.
4
Secreted Toxins and Extracellular Enzymes.分泌毒素和细胞外酶。
Microbiol Spectr. 2019 Mar;7(2). doi: 10.1128/microbiolspec.GPP3-0039-2018.
5
Staphylokinase has distinct modes of interaction with antimicrobial peptides, modulating its plasminogen-activation properties.葡萄球菌激酶与抗菌肽有不同的相互作用模式,调节其纤溶酶原激活特性。
Sci Rep. 2016 Aug 24;6:31817. doi: 10.1038/srep31817.
6
In vitro characterization of a multifunctional staphylokinase variant with reduced reocclusion, produced from salt inducible E. coli GJ1158.从盐诱导的大肠杆菌 GJ1158 中生产的具有降低再闭塞作用的多功能葡激酶变体的体外特性鉴定。
Biomed Res Int. 2013;2013:297305. doi: 10.1155/2013/297305. Epub 2013 Aug 13.
7
Bacillus anthracis interacts with plasmin(ogen) to evade C3b-dependent innate immunity.炭疽杆菌通过与纤溶酶原相互作用来逃避 C3b 依赖性固有免疫。
PLoS One. 2011 Mar 25;6(3):e18119. doi: 10.1371/journal.pone.0018119.
8
Characterization of a novel bifunctional mutant of staphylokinase with platelet-targeted thrombolysis and antiplatelet aggregation activities.具有血小板靶向溶栓和抗血小板聚集活性的新型葡萄球菌激酶双功能突变体的表征
BMC Mol Biol. 2007 Oct 7;8:88. doi: 10.1186/1471-2199-8-88.
9
Fibrinogen substrate recognition by staphylocoagulase.(pro)thrombin complexes.葡萄球菌凝固酶对纤维蛋白原底物的识别。(原)凝血酶复合物。
J Biol Chem. 2006 Jan 13;281(2):1179-87. doi: 10.1074/jbc.M507956200. Epub 2005 Oct 17.
10
(1)H, (13)C and (15)N sequence-specific resonance assignments of the two-domain thrombin inhibitor dipetalin.双结构域凝血酶抑制剂二肽他林的(1)H、(13)C和(15)N序列特异性共振归属
J Biomol NMR. 2004 Nov;30(3):383-4. doi: 10.1007/s10858-004-3496-4.